Skip to main content
. 2017 May 22;23(11):1517–1526. doi: 10.1177/1352458517696596

Figure 1.

Figure 1.

CONSORT diagram for TREFAMS-AT trial. The light grey area marks the treatment phase.

aDue to use of a website and local advertisement, the exact number of potential participants reached cannot be determined.

b90 patients with MS were included; one withdrew prior to randomization due to transport issues.